Aidence is a brand dedicated to giving lung cancer patients a fighting chance through the power of AI. With a team comprised of data scientists, software engineers, medical professionals, regulatory experts, and business professionals, Aidence is on a mission to provide intelligent software that empowers healthcare and pharmaceutical professionals to deliver faster and more precise diagnostics and treatments. They believe that data is the key to improving the prevention, management, and treatment of diseases.

Aidence has achieved remarkable milestones since its founding in 2015, including earning the CE Mark for Veye Lung Nodules, receiving a €10M series A investment, and becoming a preferred partner for the NHS England's flagship lung cancer screening program. They have also formed strategic collaborations with companies like AstraZeneca and Google Health to advance early lung cancer diagnosis using AI. In addition to their impressive track record, Aidence is committed to social responsibility.

They promote inclusivity within their organization, support lung cancer patients through sponsorship and annual fundraising events, advocate for transparency in the AI industry, and take steps to reduce their environmental footprint. Through their values of human sense, humility, accountability, transparency, and perseverance, Aidence is revolutionizing the field of healthcare with their innovative AI solutions